Screening moderate to severe obstructive sleep apnea with wearable device.

Autor: Tisyakorn J; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand., Saiphoklang N; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand., Sapankaew T; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand., Thapa K; Asian Institute of Technology School of Engineering and Technology, Pathum Thani, Thailand., Anutariya C; Asian Institute of Technology School of Engineering and Technology, Pathum Thani, Thailand., Sujarae A; Asian Institute of Technology School of Engineering and Technology, Pathum Thani, Thailand., Tepwimonpetkun C; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand. chatkarin_ball@hotmail.com.; Sleep Center of Thammasat, Thammasat University Hospital, Pathum Thani, Thailand. chatkarin_ball@hotmail.com.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Thammasat University, 99/209 Paholyotin Road, Klong Luang, 12120, Pathum Thani, Thailand. chatkarin_ball@hotmail.com.
Jazyk: angličtina
Zdroj: Sleep & breathing = Schlaf & Atmung [Sleep Breath] 2024 Dec 17; Vol. 29 (1), pp. 61. Date of Electronic Publication: 2024 Dec 17.
DOI: 10.1007/s11325-024-03232-9
Abstrakt: Background: Obstructive sleep apnea (OSA) is a highly prevalent sleep-related breathing disorder usually diagnosed through polysomnography (PSG). Moderate to severe OSA can significantly increase morbidity and mortality. Existing screening tools have limited accuracy. This study aimed to evaluate the Wellue O 2 ring, a commercial pulse oximeter ring, for screening moderate to severe OSA.
Methods: A cross-sectional study included adults aged 18 and older suspected of having OSA who underwent PSG while wearing the Wellue O2 ring on their thumb. The oxygen desaturation index (ODI) from both the O2 ring and PSG was recorded. Sensitivity, specificity, and receiver operating characteristic (ROC) curves were calculated to determine the optimal ODI cutoff value for predicting moderate to severe OSA.
Results: The study included 190 participants (53.2% male) with an average age of 43 years and an average apnea-hypopnea index (AHI) of 50.4 events per hour. Among the participants, 84.7% had moderate to severe OSA. The optimal cutoff value for 11% ODI was 1.25 events per hour lasting 20 s, with a sensitivity of 87.30% and a specificity of 78.70%. The area under the ROC curve for identifying moderate to severe OSA was 0.91.
Conclusions: The Wellue O2 ring demonstrated high accuracy in detecting moderate to severe OSA and could be a viable alternative for screening in clinical settings due to its accessibility and ease of use. However, larger studies are required to validate its clinical utility for diagnosing and managing moderate to severe OSA.
Competing Interests: Declarations. Conflict of interest: The authors declare no conflicts of interest. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. Ethical approval: This study was approved by the Human Research Ethics Committee of Thammasat University (Medicine), Thailand (IRB No. MTU-EC-IM-1-066/65 COA No. 129/2022), in full compliance with the Declaration of Helsinki, the Belmont Report, CIOMS Guidelines, and the International Conference on Harmonisation-Good Clinical Practice (ICH-GCP). All methods were performed in accordance with these guidelines and regulations. Informed consent: Informed consent was obtained from all individual participants included in the study. Disclosure statement: This study was conducted in collaboration with the Sleep Center of Thammasat (SCENT), Thammasat University Hospital and Asian Institute of Technology School of Engineering and Technology. We declare no conflicts of interest for JT, NS, TS, KT, CA, AS and CT. Their involvement in this research was solely focused on advancing scientific understanding and improving patient outcomes in the field of screening the obstructive sleep apnea. We affirm our commitment to transparency and scientific integrity in reporting the findings of this study.
(© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
Databáze: MEDLINE